|
1
|
Parsons DW, Jones S, Zhang X, Lin JC,
Leary RJ, Angenendt P, Mankoo P, Carter H, Siu IM, Gallia GL, et
al: An integrated genomic analysis of human glioblastoma
multiforme. Science. 321:1807–1812. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Huang J, Dorsey J, Chuikov S, Pérez-Burgos
L, Zhang X, Jenuwein T, Reinberg D and Berger SL: G9a and Glp
methylate lysine 373 in the tumor suppressor p53. J Biol Chem.
285:9636–9641. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kondo Y, Shen L, Ahmed S, Boumber Y,
Sekido Y, Haddad BR and Issa JP: Downregulation of histone H3
lysine 9 methyltransferase G9a induces centrosome disruption and
chromosome instability in cancer cells. PLoS One. 3:e20372008.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fuller GN and Scheithauer BW: The 2007
Revised World Health Organization (WHO) Classification of Tumours
of the Central Nervous System: newly codified entities. Brain
Pathol. 17:304–307. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lin X, Huang Y, Zou Y, Chen X and Ma X:
Depletion of G9a gene induces cell apoptosis in human gastric
carcinoma. Oncology Reports. 35:3041–3049. 2016.PubMed/NCBI
|
|
6
|
McGarvey KM, Fahrner JA, Greene E, Martens
J, Jenuwein T and Baylin SB: Silenced toumor stressor genes
reactivated by DNA demethylation do not return to a fully
euchromatic chromati state. Cancer Res. 66:3541–3549. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Stewart MD, Li J and Wong J: Elationship
between histone H3 lysine 9 methylation, transcription repression,
and heterochromatin protein 1 recruitment. Mol Cell Biol.
25:2525–2538. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
El Gazzar M, Yoza BK, Chen X, Hu J,
Hawkins GA and McCall CE: G9a and HP1 couple histone and DNA
methylation to TNFalpha transcription silencing during endotoxin
tolerance. J Biol Chem. 283:32198–32208. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wu LP, Wang X, Li L, Zhao Y, Lu S, Yu Y,
Zhou W, Liu X, Yang J, Zheng Z, et al: Histone deacetylase
inhibitor depsipeptide activates silenced genes through decreasing
both CpG and H3K9 methylation on the promoter. Mol Cell Biol.
28:3219–3235. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cai L, Ma X, Huang Y, Zou Y and Chen X:
Aberrant histone methylation and the effect of Suv39H1 siRNA on
gastric carcinoma. Oncol Rep. 31:2593–2600. 2014.PubMed/NCBI
|
|
11
|
Cattaneo F and Nucifora G: EVI1 recruits
the histone methyltransferase SUV39H1 for transcription repression.
J Cell Biochem. 105:344–352. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Goyama S, Nitta E, Yoshino T, Kako S,
Watanabe-Okochi N, Shimabe M, Imai Y, Takahashi K and Kurokawa M:
EVI-1 interacts with histone methyl transferases SUV39H1 and G9a
for transcriptional repression and bone marrow immortalization.
Leukemia. 24:81–88. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wu H, Chen X, Xiong J, Li Y, Li H, Ding X,
Liu S, Chen S, Gao S and Zhu B: Histone methyltransferase G9a
contributes to H3K27 methylation in vivo. Cell Res. 21:365–367.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yokochi T, Poduch K, Ryba T, Lu J,
Hiratani I, Tachibana M, Shinkai Y and Gilbert DM: G9a selectively
represses a class of late-replicating genes at the nuclear
periphery. Proc Natl Acad Sci USA. 106:19363–19368. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zou Y, Ma X, Huang Y, Hong L and Chiao JW:
Effect of phenylhexyl isothiocyanate on aberrant histone H3
methylation in primary human acute leukaemia. J Hematol Oncol.
5:362012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen Y, Luo J, Chen B, Wang J and Zou S:
Expression of histone methyltransferase G9a and clinical
significance in extrahepatic cholangiocarcinoma. Chin-Ger J Clin
Oncol. 7:10–13. 2008. View Article : Google Scholar
|
|
17
|
Sitailo LA, Jerome-Morais A and Denning
MF: Mcl-1 functions as major epidermal survival protein required
for proper keratinocyte differentiation. J Invest Dermatol.
129:1351–1360. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Theofilas P, Bedner P, Hüttmann K, Theis
M, Steinhäuser C and Frank S: The proapoptotic BCL-2 homology
domain 3-only protein Bim is not critical for acute excitotoxic
cell death. J Neuropathol Exp Neurol. 68:102–110. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tachibana M, Matsumura Y, Fukuda M, Kimura
H and Shinkai Y: G9a/GLP complexes independently mediate H3K9 and
DNA methylation to silence transcription. EMBO J. 27:2681–2690.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang YB, Niu HT, Chang JW, Dong GL and Ma
XB: EZH2 silencing by RNA interference inhibits proliferation in
bladder cancer cell lines. Eur J Cancer Care (Engl). 20:106–112.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bryant RJ, Winder SJ, Cross SS, Hamdy FC
and Cunliffe VT: The Polycomb group protein EZH2 regulates actin
polymerization in human prostate cancer cells. Prostate.
68:255–263. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ma DK, Chiang CH, Ponnusamy K, Ming GL and
Song H: G9a and Jhdm2a regulate embryonic stem cell fusion-induced
reprogramming of adult neural stem cells. Stem Cells. 26:2131–2141.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ikegami K, Iwatani M, Suzuki M, Tachibana
M, Shinkai Y, Tanaka S, Greally JM, Yagi S, Hattori N and Shiota K:
Genome-wide and locus-specific DNA hypomethylation in G9a deficient
mouse embryonic stem cells. Genes Cells. 12:1–11. 2007. View Article : Google Scholar : PubMed/NCBI
|
